U.S. Markets closed

Boston Scientific CEO sees stock price as 'undervalued'

Says company bought back approximately 46M shares of stock in Q3 and belief its stock price "remains undervalued...will continue to influence our balanced capital allocation strategy moving forward." Comments taken from Q3 earnings conference call.